Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel FAP-targeted Approach to Imaging Patients With or High-risk for Metastatic Prostate Cancer

NCT06675357 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.

NCT NCT06675357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06675357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel FAP-targeted Approach to Imaging Patients With or High-risk for Metastatic Prostate Cancer
Lead sponsor
University of Wisconsin, Madison
Phase
Phase 2
Overall status
Recruiting
Start date
February 27, 2026
Completion date
January 31, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer metastatic disease, prostate cancers